SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs sharp rebound and breakout have fueled bullish momentum and short-squeeze speculation, with traders pointing to Elon Musks confirmation of preliminary TSMC discussions about Terafab as a possible catalyst. Others question the valuation and warn that upcoming share unlocks could add selling pressure.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

OpenAI CEO Sam Altmans description of Cerebras as a close partner helped ease concerns after reports said OpenAIs latest ultrafast model used Nvidia GPUs, sparking a rebound in CBRS shares. Traders remain divided over whether the reassurance outweighs continuing insider share-unlock selling and uncertainty about Cerebras role in OpenAIs inference workloads.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs expanded Kentucky Power agreement doubles planned Muskie campus capacity to 1 GW and advances the second phase, though regulatory approval remains pending. Traders are split: bulls view the added power as support for its AI/HPC data-center expansion, while skeptics focus on construction costs, financing and dilution, delayed revenue, and the stocks decline despite the news.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is drawing attention after a sharp selloff, with traders pointing to weakness across restaurant and consumer-discretionary stocks amid concerns about rates and pressured consumer spending. Bearish posts also cite food quality, contamination concerns and valuation, while some traders view the pullback as a buying opportunity.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Ryan Cohens latest reported open-market share purchase, alongside a run of insider buying, is the main focus. Traders see the buying and approaching warrant expiration as potential support for a rally, while skeptics argue it needs a concrete company announcement to move the stock meaningfully.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 open-label extension data, including a reported 76% slowing of upper-limb decline after placebo patients switched to deramiocel, is driving discussion ahead of the FDAs November 22 decision. Bullish traders view the results as support for an upper-limb-focused approval, while skeptics point to the open-label design and unresolved FDA concerns; the shares have been volatile despite the data.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Bank of America upgrade to Buy, citing DraftKings prediction-market business as a potential growth driver, is behind the sharp rebound. Bulls see DKeX as an opportunity, while skeptics question its execution and point to competition, regulatory uncertainty, and the stocks prolonged decline.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3Ds sudden CFO departure and interim replacement are the main focus amid the sharp selloff. Traders are divided between viewing the change as routine, with management citing no disagreement, and seeing the short tenure and limited explanation as reasons for concern.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Shareholder approval of the Evernorth merger cleared the path for its Nasdaq debut as an XRP treasury company, with the planned holdings drawing attention from XRP-focused traders. The community is split between bullish momentum and low-float or warrant-squeeze speculation and concerns that the stocks premium to its XRP backing may unwind through profit-taking or post-merger selling.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

The upcoming earnings report is the main focus, with traders watching for revenue and guidance that demonstrate progress in Applied Digitals AI data-center buildout; discussion also highlights the 75-MW Polaris Forge 1 ready-for-service milestone. Bulls view on-schedule capacity additions and contracted demand as evidence of execution, while skeptics point to persistent share-price weakness, financing and dilution risks, and pressure from elevated Treasury yields.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VKTX Stock On Track To Beat LLY, NVO This Month After Obesity Drug Data — Can Viking Win Over Wegovy And Zepbound Users?

Equity

Obesity specialist Lou Aronne said switching from a GLP-1 drug to a dual GLP-1/GIP drug could mean greater weight loss.

VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’

Novo targets over $23 billion in risk-adjusted pipeline sales by 2035, excluding any contribution from future acquisitions.

Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?

Altimmune (ALT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is Altimmune Worth Buying as Cash Rises but Execution Risks Linger?

ALT's stronger cash position supports pemvidutide's MASH, AUD and ALD programs, but long timelines, funding needs and competition remain risks.

Altimmune's Phase III MASH Study Puts 2029 Data in Investor Focus

ALT has moved pemvidutide into Phase III MASH testing, with supportive mid-stage data, regulatory backing and a 2029 readout ahead.

Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus

KOD's Zenkuda advances toward regulatory submission as its pipeline gains momentum. Key clinical data is expected later in 2026.

ALT's Q2 Loss Narrower Than Expected, Pemvidutide's Studies in Focus

Altimmune posts a narrower Q2 loss. Its $519M in cash supports operations into 2029, while pemvidutide advances across liver and AUD studies.



BLTE Stock Rises as FDA Grants Priority Review to Tinlarebant NDA

Belite Bio's tinlarebant wins FDA priority review for Stargardt Disease, with a decision expected in February 2027 after positive phase III data.

KOD Begins Late-Stage Study of KSI-501 in Diabetic Macular Edema

Kodiak launches a global phase III study of KSI-501 in DME, testing its dual IL-6 and VEGF approach for durable disease control.

PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology tops Q2 earnings and revenue estimates, raises its 2026 guidance, and outlines upcoming alisertib study milestones as Nerlynx sales climb.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. Its lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be this week?

Stocktwits

Stocktwits Polls

Investors are closely watching management's promises of non-dilutive funding for AUD Phase 3 trials to avoid further share price dilution.

Long-term holders remain split on whether Big Pharma will strike an acquisition deal now or wait for more clinical validation.

High short interest figures and heavy dark pool activity have bulls convinced a potential violent upward reversal is building.

Debate persists over whether leadership's recent move to New Jersey and administrative hires are strategic positioning or simple corporate self-interest.

The stock's valuation is being measured against a broad pipeline including MASH, AUD, and ALD, leading some to call it severely undervalued.

Current Price	$2.69
Prev Close	$2.74
Open	$2.73
Dividend Yield	0.00%
50-Day Moving Average	$3.09
Beta	1.58
Avg. Volume	3.92M
PE Ratio	-3.47

52-Week High	$6.44
52-Week Low	$2.56
Market Capitalization	$532.01M
EPS (Annual)	-$0.9999
Price to Book	1.12
Revenue Per Employee	$719.30

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALT Fundamentals